Health
The New England Journal of Medicine Publishes Final Results from Phase 1/2 Study of Tofersen for a Genetic Form of ALS – GlobeNewswire
Tofersen is an investigational molecule for superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS), the second most common genetic form of ALS,…
- Tofersen is an investigational molecule for superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS), the second most common genetic form of ALS, a progressive neurodegenerative dise…
Continue Reading
-
Noosa News24 hours agoCouncil urged to acquire koala habitat earmarked for development
-
Noosa News15 hours agoWhat the numbers really say about Crisafulli’s crime crackdown
-
General15 hours agoThe US dollar’s demise has consequences for Australia
-
Noosa News7 hours agoForty years inside a Brisbane second-hand store